Novo CEO pressed by Senate to chop selling prices of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen explained to lawmakers the company would contemplate new talks with insurers about the record price ranges of Wegovy and copyright should they pledge to keep the medicines on their formularies. Sanders swiftly https://kethek.com/